As of 2023, the import of medicaments mixed together for therapeutic use to the Philippines stood at 16.27 million US dollars. The forecasted data from 2024 to 2028 show a consistent upward trend, with the value projected to increase from 16.518 million US dollars in 2024 to 17.535 million US dollars in 2028. The year-on-year variation for 2024-2025 is approximately 1.58%, while for 2025-2026, it is 1.53%. The period from 2026 to 2027 shows a 1.48% increase, and from 2027 to 2028, a 1.42% rise is anticipated. The Compound Annual Growth Rate (CAGR) over the last five years is estimated to be around 1.6%.
Future trends to watch for include potential changes in healthcare policies, emerging market dynamics, population health trends, and advancements in medical technologies, which could influence the import demand. Economic stability and trade relations will also play a significant role in shaping future import values.
